With eyes on Gilead, lawmakers want details on how HHS reviews possible patent infringement
A pair of lawmakers has asked the Government Accountability Office to review how the U.S. Department of Health and Human Services manages patents and licenses for medicines that were discovered, at least in part, with taxpayer dollars.
The move by Sen. Debbie Stabenow (D-Mich.) and Rep. Elijah Cummings (D-Md.) follows a ruckus over a pricey Gilead Sciences (GILD) pill for treating and preventing HIV and the role federal government may have played in discovering the medicine, which is called Truvada.
